Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
|
A
|
Ageas SA
MIL:AGS
|
BE |
|
N
|
NTT Data Group Corp
DUS:NT5
|
JP |
|
NN Group NV
AEX:NN
|
NL |
|
P
|
Paychex Inc
XBER:PCX
|
US |
|
Euroseas Ltd
NASDAQ:ESEA
|
GR |
|
FINEOS Corporation Holdings PLC
ASX:FCL
|
IE |
|
ABB India Ltd
NSE:ABB
|
IN |
|
A
|
Aeon Thana Sinsap Thailand PCL
SET:AEONTS
|
TH |
|
Coherent Corp
NYSE:COHR
|
US |
|
Atkinsrealis Group Inc
F:LAV0
|
CA |
|
Fidus Investment Corp
NASDAQ:FDUS
|
US |
|
Mesoblast Ltd
ASX:MSB
|
AU |
|
Comtech Telecommunications Corp
NASDAQ:CMTL
|
US |
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
Keppel REIT
SGX:K71U
|
SG |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
|
A
|
Apple Inc
DUS:APC
|
US |
|
TAT Technologies Ltd
NASDAQ:TATT
|
IL |
|
Flex Ltd
NASDAQ:FLEX
|
SG |
|
Diebold Nixdorf Inc
NYSE:DBD
|
US |
|
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
|
US |
|
Seatrium Limited
SGX:5E2
|
SG |
Shareholder Yield
Current shareholder yield for SUPN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
SUPN Price
Supernus Pharmaceuticals Inc
| Average Annual Return | 6.99% |
| Standard Deviation of Annual Returns | 26.28% |
| Max Drawdown | -46% |
| Market Capitalization | 2.8B USD |
| Shares Outstanding | 57 580 000 |
| Percentage of Shares Shorted | 9.99% |
